Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Prolifix identifies hydroxamate-based inhibitors of HDAC with antitumor activity

April 18, 2002

Euroscreen acquires license to hormone receptor technology

April 18, 2002

Orally active VEGFR tyrosine kinase inhibitor RWJ-417975 exerts antitumor activity in mouse models

April 18, 2002

Estrogen receptor modulators and their use described by Akzo Nobel team

April 17, 2002

AVI-4126 may be useful alone or in combination in the treatment of prostate cancer

April 17, 2002

Semisynthetic andrographolide analogue with immunomodulating and antitumor activity

April 17, 2002

AACR presentations provide further preclinical characterization of epothilone D

April 17, 2002

Novel VTA from Oxigene markedly reduces tumor blood flow and exerts potent antitumor effects

April 17, 2002

Glivec approved in Switzerland for GISTs

April 17, 2002

FDA grants priority review to Arimidex in early breast cancer

April 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...